These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 8137290)

  • 21. Chimeric bispecific OC/TR monoclonal antibody mediates lysis of tumor cells expressing the folate-binding protein (MOv18) and displays decreased immunogenicity in patients.
    Luiten RM; Warnaar SO; Sanborn D; Lamers CH; Bolhuis RL; Litvinov SV; Zurawski VR; Coney LR
    J Immunother; 1997 Nov; 20(6):496-504. PubMed ID: 9409456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cloning of cDNAs encoding the variable domains of antibody BrE-3 and construction of a chimeric antibody.
    Couto JR; Blank EW; Peterson JA; Ceriani RL
    Hybridoma; 1993 Feb; 12(1):15-23. PubMed ID: 8454302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of chimeric bispecific G250/anti-CD3 monoclonal antibody, a tool to combat renal cell carcinoma.
    Luiten RM; Coney LR; Fleuren GJ; Warnaar SO; Litvinov SV
    Br J Cancer; 1996 Sep; 74(5):735-44. PubMed ID: 8795576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production and characterization of a set of mouse-human chimeric immunoglobulin G (IgG) subclass and IgA monoclonal antibodies with identical variable regions specific for Pseudomonas aeruginosa serogroup O6 lipopolysaccharide.
    Preston MJ; Gerçeker AA; Reff ME; Pier GB
    Infect Immun; 1998 Sep; 66(9):4137-42. PubMed ID: 9712759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological characterization of a chimeric mouse-human IgM antibody directed against the 17-1A antigen.
    Fogler WE; Sun LK; Klinger MR; Ghrayeb J; Daddona PE
    Cancer Immunol Immunother; 1989; 30(1):43-50. PubMed ID: 2598174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Redirected cellular cytotoxicity by infection of effector cells with a recombinant vaccinia virus encoding a tumor-specific monoclonal antibody.
    Paul S; Bizouarne N; Dott K; Ruet L; Dufour P; Acres RB; Kieny MP
    Cancer Gene Ther; 2000 Apr; 7(4):615-23. PubMed ID: 10811480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of antigen density and antibody affinity on antibody-dependent cellular cytotoxicity: relevance for immunotherapy of carcinomas.
    Velders MP; van Rhijn CM; Oskam E; Fleuren GJ; Warnaar SO; Litvinov SV
    Br J Cancer; 1998 Aug; 78(4):478-83. PubMed ID: 9716030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and characterization of cM-T413, a chimeric anti-CD4 antibody with in vitro immunosuppressive activity.
    Looney JE; Willinger A; Lin G; Rieber EP; Riethmuller G; Ghrayeb J
    J Immunother Emphasis Tumor Immunol; 1994 Jul; 16(1):36-46. PubMed ID: 8081558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction and characterization of a functional chimeric murine-human antibody directed against human fibrin fragment-D dimer.
    Bulens F; Vandamme AM; Bernar H; Nelles L; Lijnen RH; Collen D
    Eur J Biochem; 1991 Jan; 195(1):235-42. PubMed ID: 1899382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen.
    Sahagan BG; Dorai H; Saltzgaber-Muller J; Toneguzzo F; Guindon CA; Lilly SP; McDonald KW; Morrissey DV; Stone BA; Davis GL
    J Immunol; 1986 Aug; 137(3):1066-74. PubMed ID: 3088107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
    Liao SK; Horton L; Flahart RE; O'Rear L; Crumpacker D; Imbaratto JW; Yannelli JR; Robinson RR; Oldham RK
    Hum Antibodies Hybridomas; 1990; 1(2):66-76. PubMed ID: 2103354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of monoclonal antibodies 17-1A and 323/A3: the influence of the affinity on tumour uptake and efficacy of radioimmunotherapy in human ovarian cancer xenografts.
    Kievit E; Pinedo HM; Schlüper HM; Haisma HJ; Boven E
    Br J Cancer; 1996 Feb; 73(4):457-64. PubMed ID: 8595159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of tumor-related factors of influence on the uptake of the monoclonal antibody 323/A3 in experimental human ovarian cancer.
    Kievit E; Pinedo HM; Schlüper HM; Haisma HJ; Boven E
    Int J Cancer; 1997 Apr; 71(2):237-45. PubMed ID: 9139849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological properties of chimeric domain-deleted anticarcinoma immunoglobulins.
    Slavin-Chiorini DC; Kashmiri SV; Schlom J; Calvo B; Shu LM; Schott ME; Milenic DE; Snoy P; Carrasquillo J; Anderson K
    Cancer Res; 1995 Dec; 55(23 Suppl):5957s-5967s. PubMed ID: 7493377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of human blood mononuclear cell populations in antibody dependent cellular cytotoxicity (ADCC) using two murine (CO17-1A and Br55-2) and one chimeric (17-1A) monoclonal antibodies against a human colorectal carcinoma cell line (SW948).
    Masucci G; Lindemalm C; Frödin JE; Hagström B; Mellstedt H
    Hybridoma; 1988 Oct; 7(5):429-40. PubMed ID: 3198133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapy with low and high affinity monoclonal antibodies 17-1A and 323/A3 in a nude mouse xenograft carcinoma model.
    Velders MP; van Rhijn CM; Briaire IH; Fleuren GJ; Warnaar SO; Litvinov SV
    Cancer Res; 1995 Oct; 55(19):4398-403. PubMed ID: 7671252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mouse/human chimeric Me1-14 antibody: genomic cloning of the variable region genes, linkage to human constant region genes, expression, and characterization.
    Batra SK; Niswonger ML; Wikstrand CJ; Pegram CN; Zalutsky MR; Morrison SL; Bigner DD
    Hybridoma; 1994 Apr; 13(2):87-97. PubMed ID: 8050781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice.
    Mount PF; Sutton VR; Li W; Burgess J; McKEnzie IF; Pietersz GA; Trapani JA
    Cancer Res; 1994 Dec; 54(23):6160-6. PubMed ID: 7954462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells.
    Neumaier M; Shively L; Chen FS; Gaida FJ; Ilgen C; Paxton RJ; Shively JE; Riggs AD
    Cancer Res; 1990 Apr; 50(7):2128-34. PubMed ID: 2107969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant human-mouse chimeric monoclonal antibody specific for common acute lymphocytic leukemia antigen.
    Nishimura Y; Yokoyama M; Araki K; Ueda R; Kudo A; Watanabe T
    Cancer Res; 1987 Feb; 47(4):999-1005. PubMed ID: 2948638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.